Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

hsa-miR-9 controls the mobility behavior of Glioblastoma cells via regulation of MAPK14 signaling elements.

Ben-Hamo R, Zilberberg A, Cohen H, Efroni S.

Oncotarget. 2015 Dec 21. doi: 10.18632/oncotarget.6687. [Epub ahead of print]

2.

Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools.

Volovitz I, Melzer S, Amar S, Bocsi J, Bloch M, Efroni S, Ram Z, Tárnok A.

Int Rev Immunol. 2016;35(2):116-35. doi: 10.3109/08830185.2015.1096935.

PMID:
27007190
3.

System-wide Analysis of the T Cell Response.

Covacu R, Philip H, Jaronen M, Almeida J, Kenison JE, Darko S, Chao CC, Yaari G, Louzoun Y, Carmel L, Douek DC, Efroni S, Quintana FJ.

Cell Rep. 2016 Mar 22;14(11):2733-44. doi: 10.1016/j.celrep.2016.02.056. Epub 2016 Mar 10.

4.

Experimental Support for the Ecoimmunity Theory: Distinct Phenotypes of Non-Lymphocytic Cells in SCID and Wild Type Mice.

Ochayon DE, Baranovski BM, Malkin P, Schuster R, Kalay N, Ben-Hamo R, Sloma I, Levinson J, Brazg J, Efroni S, Lewis EC, Nevo U.

Cell Transplant. 2016 Feb 2. [Epub ahead of print]

PMID:
26850009
5.

Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.

Hibsh D, Buetow KH, Yaari G, Efroni S.

Nucleic Acids Res. 2016 May 19;44(9):e81. doi: 10.1093/nar/gkw031. Epub 2016 Jan 24.

6.

Reciprocal Regulation between SIRT6 and miR-122 Controls Liver Metabolism and Predicts Hepatocarcinoma Prognosis.

Elhanati S, Ben-Hamo R, Kanfi Y, Varvak A, Glazz R, Lerrer B, Efroni S, Cohen HY.

Cell Rep. 2016 Jan 12;14(2):234-42. doi: 10.1016/j.celrep.2015.12.023. Epub 2015 Dec 31.

7.

Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish.

Shamay-Ramot A, Khermesh K, Porath HT, Barak M, Pinto Y, Wachtel C, Zilberberg A, Lerer-Goldshtein T, Efroni S, Levanon EY, Appelbaum L.

PLoS Genet. 2015 Dec 4;11(12):e1005702. doi: 10.1371/journal.pgen.1005702. eCollection 2015 Dec.

8.

A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel.

Bida O, Gidoni M, Ideses D, Efroni S, Ginsberg D.

Oncotarget. 2015 Sep 29;6(29):27880-90. doi: 10.18632/oncotarget.4944.

9.

De novo transcriptome assembly databases for the central nervous system of the medicinal leech.

Hibsh D, Schori H, Efroni S, Shefi O.

Sci Data. 2015 Apr 28;2:150015. doi: 10.1038/sdata.2015.15. eCollection 2015.

10.

Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma.

Mazan-Mamczarz K, Peroutka RJ, Steinhardt JJ, Gidoni M, Zhang Y, Lehrmann E, Landon AL, Dai B, Houng S, Muniandy PA, Efroni S, Becker KG, Gartenhaus RB.

Cell Commun Signal. 2015 Mar 1;13:15. doi: 10.1186/s12964-015-0091-0.

11.

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, Barr H, Seger D, Ferraro DA, Pareja F, Gil-Henn H, Lapidot T, Alon R, Milanezi F, Symons M, Ben-Hamo R, Efroni S, Schmitt F, Wiemann S, Caldas C, Ehrlich M, Yarden Y.

Sci Signal. 2015 Jan 20;8(360):ra7. doi: 10.1126/scisignal.2005537.

PMID:
25605973
12.
13.

Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.

Cohen H, Ben-Hamo R, Gidoni M, Yitzhaki I, Kozol R, Zilberberg A, Efroni S.

Breast Cancer Res. 2014 Nov 20;16(6):464. doi: 10.1186/s13058-014-0464-0.

14.

Heat acclimation memory: do the kinetics of the deacclimated transcriptome predispose to rapid reacclimation and cytoprotection?

Tetievsky A, Assayag M, Ben-Hamo R, Efroni S, Cohen G, Abbas A, Horowitz M.

J Appl Physiol (1985). 2014 Dec 1;117(11):1262-77. doi: 10.1152/japplphysiol.00422.2014. Epub 2014 Sep 18.

15.

PhenoNet: identification of key networks associated with disease phenotype.

Ben-Hamo R, Gidoni M, Efroni S.

Bioinformatics. 2014 Sep 1;30(17):2399-405. doi: 10.1093/bioinformatics/btu199. Epub 2014 May 7.

16.

Systems analysis utilising pathway interactions identifies sonic hedgehog pathway as a primary biomarker and oncogenic target in hepatocellular carcinoma.

Efroni S, Meerzaman D, Schaefer CF, Greenblum S, Soo-Lyu M, Hu Y, Cultraro C, Meshorer E, Buetow KH.

IET Syst Biol. 2013 Dec;7(6):243-51.

PMID:
24712101
17.

SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade.

Cashman R, Cohen H, Ben-Hamo R, Zilberberg A, Efroni S.

Oncotarget. 2014 Feb 28;5(4):1071-82.

18.

MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms.

Ben-Hamo R, Efroni S.

PLoS Comput Biol. 2013;9(11):e1003351. doi: 10.1371/journal.pcbi.1003351. Epub 2013 Nov 21.

19.

Spatial regulation dominates gene function in the ganglia chain.

Hibsh D, Schori H, Efroni S, Shefi O.

Bioinformatics. 2014 Feb 1;30(3):310-6. doi: 10.1093/bioinformatics/btt570. Epub 2013 Oct 1.

20.

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ.

Nat Immunol. 2013 Oct;14(10):1054-63. doi: 10.1038/ni.2695. Epub 2013 Sep 1.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk